Literature DB >> 16816217

Psychotic and manic-like symptoms during stimulant treatment of attention deficit hyperactivity disorder.

Randal G Ross1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16816217     DOI: 10.1176/ajp.2006.163.7.1149

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN: 0002-953X            Impact factor:   19.242


× No keyword cloud information.
  36 in total

1.  The dopamine dilemma: using stimulants and antipsychotics concurrently.

Authors:  Jason Yanofski
Journal:  Psychiatry (Edgmont)       Date:  2010-06

Review 2.  Use of Stimulants in Bipolar Disorder.

Authors:  Giulio Perugi; Giulia Vannucchi; Fulvio Bedani; Ettore Favaretto
Journal:  Curr Psychiatry Rep       Date:  2017-01       Impact factor: 5.285

Review 3.  Understanding the risk of using medications for attention deficit hyperactivity disorder with respect to physical growth and cardiovascular function.

Authors:  Benedetto Vitiello
Journal:  Child Adolesc Psychiatr Clin N Am       Date:  2008-04

Review 4.  Potential adverse effects of amphetamine treatment on brain and behavior: a review.

Authors:  S M Berman; R Kuczenski; J T McCracken; E D London
Journal:  Mol Psychiatry       Date:  2008-08-12       Impact factor: 15.992

5.  Managing the comorbidity of schizophrenia and ADHD.

Authors:  Amy Gough; Jason Morrison
Journal:  J Psychiatry Neurosci       Date:  2016-08       Impact factor: 6.186

6.  Trichotillomania, bipolar disorder and white matter hyperintensities in a six-year old girl.

Authors:  Ibone Olza-Fernández; Inmaculada Palanca-Maresca; Sara Jiménez-Fernández; María Rosario Cazorla-Calleja
Journal:  J Can Acad Child Adolesc Psychiatry       Date:  2012-08

Review 7.  Methylphenidate controlled-delivery capsules (EquasymXL, Metadate CD): a review of its use in the treatment of children and adolescents with attention-deficit hyperactivity disorder.

Authors:  Vanessa R Anderson; Gillian M Keating
Journal:  Paediatr Drugs       Date:  2006       Impact factor: 3.022

Review 8.  Adverse effects of pharmacotherapies for attention-deficit hyperactivity disorder: epidemiology, prevention and management.

Authors:  Johnny Graham; David Coghill
Journal:  CNS Drugs       Date:  2008       Impact factor: 5.749

9.  The efficacy and tolerability of methylphenidate and behavior modification in children with attention-deficit/hyperactivity disorder and severe mood dysregulation.

Authors:  James Waxmonsky; William E Pelham; Elizabeth Gnagy; Michael R Cummings; Briannon O'Connor; Antara Majumdar; Jessica Verley; Martin T Hoffman; Greta A Massetti; Lisa Burrows-MacLean; Gregory A Fabiano; Daniel A Waschbusch; Anil Chacko; Frances W Arnold; Kathryn S Walker; Allison C Garefino; Jessica A Robb
Journal:  J Child Adolesc Psychopharmacol       Date:  2008-12       Impact factor: 2.576

10.  Synergistic interaction between caloric restriction and amphetamine in food-unrelated approach behavior of rats.

Authors:  Kristine L Keller; Fiori R Vollrath-Smith; Mehrnoosh Jafari; Satoshi Ikemoto
Journal:  Psychopharmacology (Berl)       Date:  2013-10-08       Impact factor: 4.530

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.